Woodward, Inc. (FRA:WW1)

CTI BioPharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	13,362	9,174	7,093	4,924	6,212	4,259
Market Cap Growth	25.25%	29.34%	44.04%	-20.73%	45.87%	-30.37%
Enterprise Value	13,760	9,750	7,719	5,630	6,613	4,983
Last Close Price	222.00	149.36	115.74	79.98	95.52	65.95
PE Ratio	40.47	27.43	32.31	28.12	34.51	20.80
PS Ratio	4.58	3.08	2.58	2.03	3.21	2.00
PB Ratio	6.36	4.70	3.63	2.54	3.25	2.51
P/TBV Ratio	12.87	11.01	9.08	7.23	8.47	8.66
P/FCF Ratio	56.63	29.85	32.35	34.30	16.86	16.54
P/OCF Ratio	41.33	23.30	24.33	24.94	15.50	14.31
EV/Sales Ratio	4.64	3.27	2.80	2.32	3.41	2.35
EV/EBITDA Ratio	27.06	19.55	20.12	16.49	19.97	13.78
EV/EBIT Ratio	33.54	24.71	28.53	25.79	30.14	19.93
EV/FCF Ratio	58.32	31.72	35.21	39.22	17.95	19.35
Debt / Equity Ratio	0.38	0.42	0.36	0.42	0.36	0.46
Debt / EBITDA Ratio	1.71	1.61	1.81	2.35	2.06	2.11
Debt / FCF Ratio	3.37	2.66	3.22	5.71	1.89	3.01
Asset Turnover	0.76	0.79	0.75	0.60	0.56	0.64
Inventory Turnover	3.99	4.34	4.34	3.98	3.95	3.89
Quick Ratio	1.33	1.16	1.46	1.34	2.68	1.83
Current Ratio	2.04	1.89	2.38	2.43	4.00	3.09
Return on Equity (ROE)	16.76%	17.56%	11.70%	8.34%	9.92%	12.93%
Return on Assets (ROA)	5.99%	6.57%	4.58%	3.39%	3.98%	4.67%
Return on Capital (ROIC)	8.30%	9.32%	6.48%	4.67%	5.37%	6.42%
Return on Capital Employed (ROCE)	11.70%	12.80%	8.40%	6.60%	6.80%	8.40%
Earnings Yield	2.47%	3.65%	3.09%	3.56%	2.90%	4.81%
FCF Yield	1.77%	3.35%	3.09%	2.92%	5.93%	6.05%
Dividend Yield	0.44%	0.58%	0.69%	0.93%	0.51%	0.78%
Payout Ratio	16.25%	15.63%	21.96%	26.20%	17.27%	15.67%
Buyback Yield / Dilution	1.34%	-0.98%	2.80%	3.51%	-2.10%	0.45%
Total Shareholder Return	1.78%	-0.40%	3.50%	4.44%	-1.58%	1.23%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.